From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)
International Journal of Oncology · 2025
DOI: 10.3892/ijo.2025.5781 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Tianxiang Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cance…. Hauptthemen laut MEDLINE: Ferroptosis, Mitochondria, Neoplasms, Radioimmunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 430 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Ferroptosis is an iron‑dependent, lipid peroxidation‑driven form of regulated immunogenic cell death (ICD). ICD has demonstrated potential to overcome resistance to conventional cancer therapies, enhancing the efficacy of treatments such as chemotherapy, radiotherapy, immunotherapy and photodynamic therapy. Notably, in the context of radiotherapy, ferroptosis serves a key role, particularly when combined with radioimmunotherapy. Mitochondria are central to the regulation of radiation‑induced oxidative stress and the remodeling of the immune microenvironment, and they undergo characteristic morphological changes during the ferroptotic process. However, the precise regulatory association between mitochondrial dysfunction and ferroptosis remains incompletely understood, and there is an ongoing debate regarding this complex interaction. The present review aimed to explore the mechanisms through which mitochondria and ferroptosis interact in the context of radiotherapy, with a focus on how ferroptosis exacerbates mitochondrial dysfunction. Additionally, the present review proposed novel strategies leveraging radioimmunotherapy to offer more precise and effective approaches for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, P.R. China.
Zitieren
APA
Wang, T., Zhou, X., Yin, X., Zhang, A., Fan, Y., Chen, K., Tao, H., Tang, Z., Zhang, P., He, X., & Yin, L. (2025). From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5781
Vancouver
Wang T, Zhou X, Yin X, Zhang A, Fan Y, Chen K, et al. From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5781
BibTeX
@article{Wang2025,
author = {Wang, Tianxiang and Zhou, Xuemei and Yin, Xinhao and Zhang, Axue and Fan, Yaxuan and Chen, Kun and Tao, Haojun and Tang, Zhongxin and Zhang, Pingchuan and He, Xia and Yin, Li},
title = {From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)},
journal = {International Journal of Oncology},
year = {2025},
doi = {10.3892/ijo.2025.5781}
}
EUVIMED